Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Primary biliary cirrhosis

Renaming primary biliary cirrhosis—clarity or confusion?

Nature Reviews Gastroenterology & Hepatology volume 12, pages 678–679 (2015)Cite this article

Subjects

What is in a name; and why does the nomenclature of one disease, primary biliary cirrhosis, cause such contention that a proposed name change by those deeply committed to the advancement of its understanding and management stimulate huge debate?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Development of liver cirrhosis as part of the natural history in PBC.

References

  1. Trivedi, P. J. et al. Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response. J. Hepatol. 60, 1249–1258 (2014).

    Article  CAS  Google Scholar 

  2. Lammers, W. J. et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology http://dx.doi.org/10.1053/j.gastro.2015.07.061.

  3. Carbone, M. et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 144, 560–569 (2013).

    Article  CAS  Google Scholar 

  4. Sherlock, S. & Scheuer, P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N. Engl. J. Med. 289, 674–678 (1973).

    Article  CAS  Google Scholar 

  5. Beuers, U. et al. Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'. Hepatology http://dx.doi.org/10.1002/hep.28140.

  6. Degott, C. et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 29, 1007–1012 (1999).

    Article  CAS  Google Scholar 

  7. Trivedi, P. J., Corpechot, C., Pares, A. & Hirschfield, G. M. Risk Stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists. Hepatology http://dx.doi.org/10.1002/hep.28128.

  8. Hirschfield, G. M., Thain, C., Walmsley, M., Brownlee, A. & Jones, D. E. Liver disease in the UK. Lancet 385, 503 (2015).

    Article  Google Scholar 

  9. Corpechot, C. et al. Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis. J. Hepatol. 56, 218–224 (2012).

    Article  CAS  Google Scholar 

  10. Hirschfield, G. M. et al. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology 148, 751–761 (2015).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

P.J.T. has received funding from the NIHR Birmingham Liver Biomedical Research Unit and is in receipt of a Wellcome Trust funded Clinical Research Fellowship. G.M.H. has received funding from the NIHR Birmingham Liver Biomedical Research Unit and is a co-investigator for UK-PBC supported by a Stratified Medicine Award from the UK Medical Research Council. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health.

Author information

Authors and Affiliations

  1. National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Institute of Immunology and Immunotherapy, University of Birmingham, Wolfson Drive, Birmingham, B15 2TT, UK

    Palak J. Trivedi & Gideon M. Hirschfield

Authors
  1. Palak J. Trivedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gideon M. Hirschfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gideon M. Hirschfield.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trivedi, P., Hirschfield, G. Renaming primary biliary cirrhosis—clarity or confusion?. Nat Rev Gastroenterol Hepatol 12, 678–679 (2015). https://doi.org/10.1038/nrgastro.2015.187

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2015.187

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing